Skip to main content
Log in

Combination Therapy with Carvedilol and Nicardipine in Essential Hypertension

An Open Study

  • Short Communications
  • Poster Presentation
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Abshagen U. A new molecule with vasodilating and β-adrenoceptor blocking properties. Journal of Cardiovascular Pharmacology 10 (Suppl. 11): 23–32, 1987

    Google Scholar 

  • Anderton JL, Vallance BD, Stanley NN, Crowe PF, Mittra B, et al. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study. Drugs 35 (Suppl. 4): 22–26, 1988

    Article  PubMed  Google Scholar 

  • Daniels AR. Opie LH. Atenolol plus nifedipine for mild to moderate hypertension after fixed doses of either agent alone. American Journal of Cardiology 57: 965–970, 1986

    Article  PubMed  CAS  Google Scholar 

  • de Devitiis O, Petitto M, Di Somma S, Galderisi M, Villari B, et al. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension. Arzneimittel-Forschung 35: 727–729, 1985

    Google Scholar 

  • Ekelund L-G. Nifedipine in combination therapy for chronic hypertension. American Journal of Medicine 79 (Suppl. 4A): 41–43, 1985

    Article  PubMed  CAS  Google Scholar 

  • Heber ME, Brigden GS, Caruana MP, Lahiri A, Raftery EB. Carvedilol for systemic hypertension. Journal of Cardiovascular Pharmacology 10 (Suppl. 11): 113–118, 1987

    Google Scholar 

  • Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The 1984 Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Archives of Internal Medicine 144: 1045–1057, 1984

    Article  Google Scholar 

  • Maclean D. Aims of combination therapy — improved quality of life or better blood pressure control? Drugs 35 (Suppl. 4): 16–21, 1988

    Article  PubMed  Google Scholar 

  • Morgan T, Snowden R, Butcher L. Effect of carvedilol and metoprolol on blood pressure, blood flow and vascular resistance. Journal of Cardiovascular Pharmacology 10 (Suppl. 11): 124–129, 1987

    Google Scholar 

  • Ogihara T, Ikeda M, Goto Y, Yoshinaga K, et al. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension. Journal of Cardiovascular Pharmacology 10 (Suppl. 11): 108–112, 1987

    Google Scholar 

  • Ogihara T, Goto Y, Yoshinaga K, Kumahara Y, Iimura O, et al. Dose-effect relationship of carvedilol in essential hypertension. Drugs 36 (Suppl. 6): 75–81, 1988

    Article  PubMed  Google Scholar 

  • Opie LH, Lee J, White D. Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol. American Heart Journal 104: 606–612, 1982

    Article  PubMed  CAS  Google Scholar 

  • Schnurr E, Widmann L, Glocke M. Efficacy and safety of carvedilol in the treatment of hypertension. Journal of Cardiovascular Pharmacology 10 (Suppl. 11): 101–107, 1987

    Google Scholar 

  • Sorkin EM, Clissold SP, Brogden RN. Nifedipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 30: 182–274, 1985

    Article  PubMed  CAS  Google Scholar 

  • Sponer G, Bartsch W, Strein K, Müller-Beckmann B, Bohem E. The pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties. Journal of Cardiovascular Pharmacology 9: 317–327, 1986

    Article  Google Scholar 

  • Takabatake T, Ohta H, Yamamoto Y, Ishida Y, et al. Combination therapy with an alpha- and beta-blocking agent, amosulalol and a calcium antagonist, nicardipine in essential hypertension. Clinical Report 20: 311–317, 1986

    Google Scholar 

  • Takenaka T, Handa J. Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients. International Journal of Clinical Pharmacology and Biopharmacology 17: 1–11, 1979

    CAS  Google Scholar 

  • Wathen CG, Hannan WJ, Turnbull LW, Muir AL. Afterload reduction by nifedipine — the acute haemodynamic response to exercise in hypertensive subjects. European Heart Journal 6: 358–364, 1985

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takabatake, T., Ohta, H., Yamamoto, Y. et al. Combination Therapy with Carvedilol and Nicardipine in Essential Hypertension. Drugs 36 (Suppl 6), 124–128 (1988). https://doi.org/10.2165/00003495-198800366-00021

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800366-00021

Keywords

Navigation